Real-world patient characteristics associated with survival of 2 years or more after radium-223 treatment for metastatic castration-resistant prostate cancer (EPIX study)
暂无分享，去创建一个
N. Agarwal | K. Miller | C. Higano | B. Tombal | C. Sternberg | O. Sartor | D. George | Helen Guo | N. Shore | J. Reeves | P. Sandström | N. Constantinovici | X. Jiao | F. Saad | F. Verholen